Picture of Orexo AB logo

ORX Orexo AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Orexo AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-19.9-214-184-110-140
Depreciation
Non-Cash Items-46-69.8-72.222.8-25.5
Unusual Items
Other Non-Cash Items
Changes in Working Capital43.7230.8-85.3-56.1
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities16.7-229-157-95-32.7
Capital Expenditures-190-52.8-23.9-19.2-4.7
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.6-0.1-211220-0.6
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-189-52.9-235201-5.3
Financing Cash Flow Items0.1
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-111251-21.4-70.1-15.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-312-1.2-37238.8-47.7